Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Position- Policy Researcher – Internship Company: European Institute of Policy Research and Human Rights AISBL Location: Remote Duration: 8 weeks About the Internship The European Institute of Policy Research and Human Rights AISBL invites applications for